Secondary prevention of myocardial infarction: new horizons forpharmacotherapy. SymposiumTAYLOR, S. H.European heart journal. 1996, Vol 17, Num DEC, issn 0195-668X, 49 p., SUPFConference Proceedings

Treatment for acute myocardial infarction : Overview of randomized clinical trialsYUSUF, S; ANAND, S; AVEZUM, A. JR et al.European heart journal. 1996, Vol 17, Num DEC, pp 16-29, issn 0195-668X, SUPFConference Paper

Secondary preventive potential of nitrates in ischaemic heart diseaseTHADANI, U.European heart journal. 1996, Vol 17, Num DEC, pp 30-36, issn 0195-668X, SUPFConference Paper

Secondary preventive potential of lipid-lowering drugs : the bezafibrate coronary atheroslerosis intervention trial (BECAIT)DE FAIRE, U; ERICSSON, C.-G; GRIP, L et al.European heart journal. 1996, Vol 17, Num DEC, pp 37-42, issn 0195-668X, SUPFConference Paper

The role of thrombolytic drugs in the management of myocardial infarction : Comparative clinical trialsWEAVER, W. D.European heart journal. 1996, Vol 17, Num DEC, pp 9-15, issn 0195-668X, SUPFConference Paper

Troponin T : a diagnostic marker for myocardial infarction and minor cardiac cell damageROTTBAUER, W; GRETEN, T; MÜLLER-BARDORFF, M et al.European heart journal. 1996, Vol 17, Num DEC, pp 3-8, issn 0195-668X, SUPFConference Paper

The association between cardiac events and myocardial ischaemia following thrombolysis in acute myocardial infarction and the impact of carvedilolBASU, S; SENIOR, R; RAFTERY, E. B et al.European heart journal. 1996, Vol 17, Num DEC, pp 43-47, issn 0195-668X, SUPFConference Paper